Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 52, 2489-2496, May 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henderson, B. R.
Right arrow Articles by Kefford, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henderson, B. R.
Right arrow Articles by Kefford, R. F.

Transcriptional and Posttranscriptional Activation of Urokinase Plasminogen Activator Gene Expression in Metastatic Tumor Cells1

Beric R. Henderson2, William P. Tansey, Susan M. Phillips, Ian A. Ramshaw and Richard F. Kefford

Medical Oncology Unit, Department of Medicine, University of Sydney, Westmead Hospital, Westmead, New South Wales 2145 [B. R. H., W. P. T., R. F. K.] and Division of Cell Biology, John Curtin School of Medical Research, Australian National University, P. O. Box 334, Canberra, A.C.T. 2601 [S. M. P., I. A. R.], Australia

Urokinase plasminogen activator (uPA) is a serine protease which has frequently been implicated in the process of tumor cell invasion and metastasis. The degree of expression and mode(s) of regulation of the uPA gene in metastatic compared with nonmetastatic tumor cells have not yet been addressed. We have cloned and sequenced a full-length rat uPA complementary DNA and utilized Northern blot analysis to report that the uPA gene is expressed at levels 3.5- to 70-fold higher in metastatic cell lines than in nonmetastatic cell lines derived from two independent rat mammary adenocarcinomas. Nuclear run-on assays and RNA half-life estimations indicated that metastatic MAT 13762 rat mammary adenocarcinoma cells expressed 3.5-fold higher levels of uPA RNA than a nonmetastatic derivative (J-clone), due to a combined increase in uPA gene transcription and cytoplasmic RNA stability. By contrast, uPA RNA (and enzyme) levels were elevated by up to 70-fold in metastatic clones of dimethylbenz(a)anthracene-induced rat mammary adenocarcinoma (DMBA-8) due to predominantly posttranscriptional mechanisms. Moreover, treatment of nonmetastatic DMBA-8 cell lines with protein synthesis inhibitors led to an increase in nuclear and cytoplasmic uPA RNA levels, without altering the rate of uPA gene transcription. These results suggest that in addition to gene transcription, posttranscriptional events localized in the nucleus and cytoplasm are key determinants of uPA gene activation in rat mammary adenocarcinomas.

1 This work was supported in part by a grant from the University of Sydney Cancer Research Fund.

2 To whom requests for reprints should be addressed. Recipient of a Research Fellowship from the University of Sydney Medical Foundation.

Received 6/21/91. Accepted 2/26/92.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Shetty and S. Idell
Post-transcriptional Regulation of Urokinase mRNA. IDENTIFICATION OF A NOVEL UROKINASE mRNA-BINDING PROTEIN IN HUMAN LUNG EPITHELIAL CELLS IN VITRO
J. Biol. Chem., April 28, 2000; 275(18): 13771 - 13779.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Schloesser, S. Zeerleder, G. Lutze, W.-M. Halbmayer, S. Hofferbert, B. Hinney, H. Koestering, B. Lammle, G. Pindur, K. Thies, et al.
Mutations in the Human Factor XII Gene
Blood, November 15, 1997; 90(10): 3967 - 3977.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1992 by the American Association for Cancer Research.